Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 12,152 |
| Other current assets | 0 | 213 |
| TOTAL | $0 | $12,365 |
| Non-Current Assets | ||
| PPE Net | N/A | 406 |
| Other Non-Current Assets | 0 | 10 |
| TOTAL | $N/A | $416 |
| Total Assets | $0 | $12,599 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 0 | 40 |
| Accounts payable and accrued liabilities | 0 | 340 |
| Accrued Expenses | 0 | 500 |
| TOTAL | $0 | $890 |
| Non-Current Liabilities | ||
| Long Term Debt | 0 | 163 |
| Other Non-Current Liabilities | 0 | 5 |
| TOTAL | $N/A | $173 |
| Total Liabilities | $0 | $1,063 |
| Shareholders' Equity | ||
| Common Shares | 0 | 1 |
| Retained earnings | 0 | -7,108 |
| Other shareholders' equity | 0 | 17,743 |
| TOTAL | $0 | $11,536 |
| Total Liabilities And Equity | $0 | $12,599 |